Klotho Neurosciences Files 8-K on Agreements

Ticker: GRMLW · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1907223

Sentiment: neutral

Topics: material-agreement, equity-sale, corporate-action

Related Tickers: KLTO

TL;DR

Klotho Neurosciences (KLTO) filed an 8-K detailing new agreements and equity sales.

AI Summary

Klotho Neurosciences, Inc. filed an 8-K on June 11, 2025, reporting on an entry into a material definitive agreement and unregistered sales of equity securities. The filing also includes financial statements and exhibits. The company was formerly known as ANEW Medical, Inc. and Redwoods Acquisition Corp.

Why It Matters

This filing indicates significant corporate actions and potential financial transactions for Klotho Neurosciences, Inc., which could impact its future operations and investor outlook.

Risk Assessment

Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can carry inherent risks related to terms, dilution, and regulatory compliance.

Key Players & Entities

FAQ

What type of material definitive agreement did Klotho Neurosciences enter into?

The filing indicates an entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.

What was the date of the name change from ANEW Medical, Inc. to Klotho Neurosciences, Inc.?

The date of the name change from ANEW Medical, Inc. was June 24, 2024.

What is the Standard Industrial Classification code for Klotho Neurosciences, Inc.?

The SIC code is 2836, for BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).

What is the SEC file number for Klotho Neurosciences, Inc.?

The SEC file number is 001-41340.

What other former company name is listed for Klotho Neurosciences, Inc.?

The company was also formerly known as Redwoods Acquisition Corp., with a name change date of January 27, 2022.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding Klotho Neurosciences, Inc. (GRMLW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing